European prize for mobile vaccination units The Netherlands’ mobile vaccination units (prikbussen) have been selected as a best-practice method for the European project ‘Overcoming Obstacles to Vaccination’.
Concerns over falling vaccination coverage within National Immunisation Programme The percentage of children vaccinated within the National Immunisation Programme (NIP) has fallen for the second year in a row, according to the 2022 report ‘Vaccination Coverage and Annual Report of the Dutch National Immunisation Programme'. RIVM is concerned about this decline.
From 1 October 2023, heel prick test also screens for metabolic disorder ALD From 1 October 2023, the blood of newborn babies will also be tested for the metabolic disorder adrenoleukodystrophy (ALD). This is done with the heel prick screening test.
Night shift workers more likely to have poor work-life balance People who work at night are more than 2.5 times more likely to have a poor work-life balance. They find it more difficult to combine their jobs and private lives than people who only work in daytime. This is one of the results of a study by RIVM and TNO.
NIPT available as standard option for all pregnant women from 1 April From 1 April 2023, the Non-Invasive Prenatal Test (NIPT) will be available to all pregnant women. They do not have to take part in a scientific study for this.
Less than half of Dutch people met the Physical Activity Guidelines in 2021 In 2021, 47% of people aged four years and older in the Netherlands got the amount of physical activity recommended by the Physical Activity Guidelines. Children aged 4 to 11 years were most likely to meet the standard. Conversely, young people between the ages of 12 and 17 fell short. This is the outcome of a study conducted by RIVM.
People working from home more likely to have health problems People who worked from home during the COVID-19 pandemic were more likely to have physical complaints than people working on location (location workers). Examples included upper back pain, lower back pain, and pain in arms, neck and/or shoulders. These findings are from RIVM research.
RIVM and TNO describe impact of future developments on occupational health and safety RIVM and the Netherlands Organisation for Applied Scientific Research (TNO) have investigated the potential impact of developments in the next 20 years on occupational health and safety. How will artificial intelligence affect safety at work? iStock
Provisional figures on participation in the National Immunisation Programme According to RIVM’s registration system, at least 90% of babies have been vaccinated against mumps, measles and rubella (MMR).
Safe working practices: RIVM creates a list of 1,400 substances without a European occupational exposure limit for health purposes Employees sometimes come into contact with hazardous substances at work. RIVM has compiled a list of 1,400 hazardous substances for which the European Commission has not yet set an occupational exposure limit.